Skip to content

van Houte Hans

Reporting owner on Forms 3, 4 and 5, CIK 1817217.

van Houte Hans reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-04.

Issuers

IssuerRoles in the latest filingFilingsLast filed
NRIX · Nurix Therapeutics, Inc.CIK 1549595officer (Chief Financial Officer)22026-11-04

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
NRIX · Nurix Therapeutics, Inc.Common Stock2026-11-04S sold-3,300$15.382444,214Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-11-04S sold-1,469$16.201842,745Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+3,750$043,916Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+2,859$046,775Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+3,573$050,348Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30S sold-2,834$26.279147,514Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-3,750$07,500Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-2,859$017,150Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-3,573$035,730Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001817217-26-000016 Nurix Therapeutics, Inc.2026-11-04
Form 4 0001817217-26-000014 Nurix Therapeutics, Inc.2026-11-02